Pictured from left to right: Ravi Jain, Isabel Bjork, Rob Currie and Ann Pace
SANTA CRUZ, CA – March 24, 2017 – Today, the UC Santa Cruz Genomics Institute held a going-away party for its Managing Director, Ravi Jain, at Santa Cruz’s Discretion Brewery. Jain, who has been with the Institute for two years, says he intends to return to for-profit enterprise in the biotech/bioinformatics space.
“Ravi’s outside perspective coming from a background of successful startups has been incredibly valuable,” Scientific Director David Haussler said. “He worked hard and now we are on an outstanding trajectory,” he continued. “I understand completely that he is yearning for a different challenge now. We wish him all the best and thank him deeply for his contributions to our effort,” Haussler concluded.
Haussler added that he is grateful to Ann Pace, Director, Research Development and Isabel Bjork, Director, Pediatric Cancer Precision Medicine for agreeing to help guide the Institute. “Ann and Isabel’s continued leadership and guidance provides us strong continuity and stability during this transition,” Haussler said. Pace will lead the finance and grants side; and Bjork will handle operations and development for the GI, while maintaining her role leading the Treehouse Childhood Cancer Initiative. In addition, Rob Currie will be continuing to lead the technical direction of the GI in the CTO position.
About the UC Santa Cruz Genomics Institute
Comprised of diverse researchers from a variety of disciplines across academic divisions, the UC Santa Cruz Genomics Institute leads global efforts to unlock the world’s genomic data and accelerate breakthroughs in health and evolutionary biology. Our platforms, technologies, and scientists unite diverse, distributed communities to create and deploy data-driven, life-saving treatments and innovative conservation efforts.